Aspen Aerogels (ASPN) Misses Q4 EPS by 21c, Offers Guidance

Aspen Aerogels (NYSE: ASPN) reported Q4 EPS of ($0.50), $0.21 worse than the analyst estimate of ($0.29). Revenue for the quarter came in at $31.5 million versus the consensus estimate of $34.46 million.

GUIDANCE:

Aspen Aerogels sees FY2022 EPS of ($1.95)-($2.07), versus the consensus of ($0.98). Aspen Aerogels sees FY2022 revenue of $145-155 million, versus the consensus of $151 million.

For earnings history and earnings-related data on Aspen Aerogels (ASPN) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• JPMorgan Starts ICICI Prudential Asset Management (ICICIAMC:IN) at Overweight
• RBC Capital Starts Molina Healthcare (MOH) at Sector Perform